-
AVOIDABLE HYPERTENSIVE ADMISSIONS: ACUTE COMPLICATIONS AND HOSPITAL UTILIZATION IN CHILE’S PUBLIC SECTOR
Mar 18, 2026, 21:38 PM -
REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) CAPTURES A 2025 STANDARD-OF-CARE (SOC) SHIFT DRIVEN BY ANTIBODY-DRUG CONJUGATES (ADCS) IN UROTHELIAL CARCINOMA (UC): IMPLICATIONS FOR HEALTH TECHNOLOGY ASSESSMENTS (HTAS)
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SCREENING AND INTERVENTION STRATEGIES FOR PERINATAL DEPRESSION USING MULTI-STATE MARKOV MODEL IN RURAL CHINA
Mar 18, 2026, 21:38 PM -
BEYOND COST AND QALYS: INTEGRATING THE APP SCORE TO IMPROVE COST-EFFECTIVENESS ANALYSIS OF DIGITAL HEALTH TECHNOLOGIES
Mar 18, 2026, 21:38 PM -
CLINICAL TRIAL EVIDENCE SUPPORTING FDA APPROVAL OF NOVEL AGENTS IN 2024
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF TUMOR TREATING FIELDS PLUS RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
EXAMINING PLAN-LEVEL BID DEVIATIONS IN MEDICARE PART D: EVIDENCE FROM 2016-2025
Mar 18, 2026, 21:38 PM -
ECONOMIC ANALYSES OF GENDER-AFFIRMING CARE: A LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
ECONOMIC AND EPIDEMIOLOGICAL BURDEN OF DIABETES IN MAGHREB COUNTRIES: ALGERIA, TUNISIA, AND MOROCCO
Mar 18, 2026, 21:38 PM -
A LONG-TERM COST-EFFECTIVENESS MODELLING STUDY OF SEMAGLUTIDE FOR THE TREATMENT OF ADULTS WITH OVERWEIGHT AND OBESITY IN CHINA
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE U.S. MEDICAID POPULATION BY FEDERAL POVERTY LEVEL: DEMOGRAPHICS, REGIONAL PATTERNS, AND AFFORDABLE CARE ACT (ACA) EXPANSION STATUS TO ASSESS POLICY SHIFTS UNDER THE ONE BIG BEAUTIFUL BILL ACT (H.R.1)
Mar 18, 2026, 21:38 PM -
REAL WORLD INSIGHTS INTO OBESITY CARE: UNDERSTANDING TREATMENT PATTERNS AND PAYER COSTS AT AN INTEGRATED HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
COMPARING THECOSTEFFECTIVENESS OFONSITEBUPRENORPHINE TREATMENT VERSUSTREATMENT FACILITY REFERRALATHARM REDUCTION AGENCIES
Mar 18, 2026, 21:38 PM -
IMPACT OF STATE-LEVEL INSULIN OUT-OF-POCKET SPENDING CAPS ON UTILIZATION OF PREFERRED NON-INSULIN MEDICATIONS FOR TYPE 2 DIABETES
Mar 18, 2026, 21:38 PM -
ALTERNATIVE ANALYTICAL APPROACHES TO INVESTIGATING THE ASSOCIATION BETWEEN TIMELINESS OF LUNG CANCER TREATMENT AND SURVIVAL
Mar 18, 2026, 21:38 PM -
REAL-WORLD CLINICAL CHARACTERISTICS AND FACTORS ASSOCIATED WITH CONCURRENT GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1 RA) THERAPY AMONG PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) PRESCRIBED RESMETIROM
Mar 18, 2026, 21:38 PM -
ADVANCING EQUITY IN PROSTATE CANCER RESEARCH: STRATEGY AND OUTCOMES FROM A PROSPECTIVE ENROLLMENT INITIATIVE
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION AMONG ADULTS WITH MIGRAINE IN A COMMERCIALLY INSURED US POPULATION (IFORM-II)
Mar 18, 2026, 21:38 PM -
COMPARISON OF ISCHEMIC STROKE INCIDENCE RATES IN HUNGARY AND EUROPE BASED ON DATA FROM THE GLOBAL BURDEN OF DISEASE STUDY
Mar 18, 2026, 21:38 PM -
COMPARABILITY OF OPEN AND CLOSED CLAIMS DATA FOR HEALTHCARE RESOURCE UTILIZATION ASSESSMENT IN ACUTE ISCHEMIC STROKE
Mar 18, 2026, 21:38 PM
